St. Jude Medical landed European regulatory approval for the Invisible Trial System for use in identifying patients as candidates for Spinal Cord stimulation therapy. The **n-implantable device communicates with a paired iPad mini via which physicians can program the stimulator and analyze results, while a paired iPod Touch can be used by the patient to adjust therapy throughout the day. Because there are ** wires, the System can remain completely hidden under clothes, hence the word “invisible” in the product name.
The device is capable of delivering traditional tonic as well as burst stimulation to be able to cover the widest array of patients that could benefit from Spinal Cord stimulation. The accompanying software provides visualization of the leads and their positioning, as well as the contact that they make with the body.
“We’ve developed our new patient-centric Invisible Trial System as a response to physician and patient feedback,” said Eric S. Fain, M.D., group president of St. Jude Medical, in a statement. “The System was designed to improve the comfort and usability of our System for patients evaluating Spinal Cord stimulation therapy to alleviate their chronic pain without focusing on potential barriers such as programming Trial cables and systems with complex Trial controls.”
06-08-2015, 09:31 PM
St. Jude Medical’s Invisible Trial System Helps Predict Effect of Spinal Cord Stimula
العرض العادي
